SZ
StageZero Life Sciences Ltd.
SZLSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $630.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.17x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 201.33%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 300.79%
Op. margin 204.13%
FCF margin 92.98%
Quality
79 /100
Excellent ROA 1,629.25%
Asset turnover 5.42x
ROIC 151.85%
Debt
50 /100
Moderate Int. coverage -37.63x
Net debt/EBITDA -0.17x
Current ratio 0.04x
Stability
35 /100
Moderate Rev. volatility 1,671.49%
EPS volatility 21.89%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SZLSF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James R. Howard-Tripp
Employees
40
Headquarters
Richmond Hill
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report